Disc Medicine, Inc. - Common Stock (NQ:IRON)

79.90 +3.01 (+3.91%)

Streaming Delayed Price Updated: 3:44 PM EST, Dec 31, 2025 Add to My Watchlist

Price and Volume

Volume	191,380
Open	77.08
Bid (Size)	79.78 (100)
Ask (Size)	80.16 (100)
Prev. Close	76.89
Today's Range	76.80 - 80.32
52wk Range	30.82 - 99.50
Shares Outstanding	22,877,552
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ ↗

December 19, 2025

Stat News on Friday raised concerns for Biopertin’s expedited approval under the FDA Commissioner's National Priority Voucher program.

Via Stocktwits

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

December 06, 2025

From Disc Medicine Inc

Via GlobeNewswire

Performance

YTD	+27.9%	+27.9%
1 Month	-12.9%	-12.9%
3 Month	+20.9%	+20.9%
6 Month	+56.3%	+56.3%
1 Year	+29.7%	+29.7%

More News

Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗

November 19, 2025

Via The Motley Fool

Disc Medicine Inc (NASDAQ:IRON) Reports Wider-Than-Expected Q3 2025 Loss Amid Pipeline Advancements ↗

November 06, 2025

Via Chartmill

Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update

November 06, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

November 03, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine to Participate in Upcoming Investor Conferences

October 31, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

October 21, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

October 20, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones

October 20, 2025

From Disc Medicine Inc

Via GlobeNewswire

Top stock movements in today's session. ↗

October 17, 2025

Via Chartmill

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings ↗

October 17, 2025

Via Benzinga

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

October 17, 2025

Via Chartmill

The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗

October 17, 2025

Via Investor's Business Daily

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗

October 17, 2025

Via Benzinga

Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week

October 17, 2025

From Disc Medicine Inc

Via GlobeNewswire

Discover the top movers in Friday's pre-market session. ↗

October 17, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 17, 2025

Via Benzinga

Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗

October 17, 2025

Via Stocktwits

Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)

October 16, 2025

From Disc Medicine Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 16, 2025

Via Benzinga

Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides

October 14, 2025

Via MarketMinute

Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)

September 30, 2025

From Disc Medicine Inc

Via GlobeNewswire

Disc Medicine to Participate in Upcoming Investor Conferences

August 27, 2025

From Disc Medicine Inc

Via GlobeNewswire

Frequently Asked Questions

Is Disc Medicine, Inc. - Common Stock publicly traded?

Yes, Disc Medicine, Inc. - Common Stock is publicly traded.

What exchange does Disc Medicine, Inc. - Common Stock trade on?

Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Disc Medicine, Inc. - Common Stock?

The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market

What is the current price of Disc Medicine, Inc. - Common Stock?

The current price of Disc Medicine, Inc. - Common Stock is 79.90

When was Disc Medicine, Inc. - Common Stock last traded?

The last trade of Disc Medicine, Inc. - Common Stock was at 12/31/25 03:44 PM ET

What is the market capitalization of Disc Medicine, Inc. - Common Stock?

The market capitalization of Disc Medicine, Inc. - Common Stock is 1.83B

How many shares of Disc Medicine, Inc. - Common Stock are outstanding?

Disc Medicine, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.